Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • China slaps anti...

    China slaps anti dumping duties on chemical from India, Japan

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-01-24T09:00:49+05:30  |  Updated On 24 Jan 2019 9:00 AM IST
    China slaps anti dumping duties on chemical from India, Japan

    Significantly, the anti-dumping duties announcement coincided with the trade talks between visiting Commerce Secretary Anup Wadhawan and Chinese Vice Commerce Minister Wang Shouwen here on Tuesday.


    China: China has imposed anti-dumping duties on ortho-dichlorobenzene(ODCB) imported from India and Japan which will come into effect from Wednesday.


    The domestic industry has been subject to substantial damages due to the dumping of these products, the Chinese Commerce Ministry said on Tuesday in a final ruling after anti-dumping investigations into the imports.


    Significantly, the anti-dumping duties announcement coincided with the trade talks between visiting Commerce Secretary Anup Wadhawan and Chinese Vice Commerce Minister Wang Shouwen here on Tuesday.


    The two sides also held a detailed discussion on the widening trade deficit which last year climbed to USD 57.86 billion in the total USD 95.54 total bilateral trade.


    From Wednesday, duties will be collected at rates ranging from 31.9 per cent to 70.4 per cent for a five-year period, the Chinese Commerce Ministry said, state-run Xinhua news agency reported.


    After receiving complaints from the domestic industry, the ministry launched the anti-dumping investigations in January 2018, and a preliminary ruling was unveiled in October 2018.


    ODCB can be used for producing chemical products that are widely used in making pesticides, medicine and dyes.


    Also Read: China removes import duties on 28 medicines; India to get a boost

    Anti-DumpingAnup Wadhawanbilateral tradechinaChinese commerce ministrydyesIndiainvestigationsJapanmedicineODCBpesticidesslapsUSDWang ShouwenXinhua
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok